80 related articles for article (PubMed ID: 11829939)
1. [Expression and regulation of p16 in osteosarcoma].
Shi X; Ma Z; Wang D; Liang Y; Li H; Wang J
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):733-6. PubMed ID: 11829939
[TBL] [Abstract][Full Text] [Related]
2. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer.
Kusume T; Tsuda H; Kawabata M; Inoue T; Umesaki N; Suzuki T; Yamamoto K
Clin Cancer Res; 1999 Dec; 5(12):4152-7. PubMed ID: 10632354
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
4. [The effects of exogenous p16 expression on CDK4, Cyclin D1 and pRb in nasopharyngeal carcinoma cell lines].
Zhao XR; Deng L; Weng XX
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):428-30. PubMed ID: 12212108
[TBL] [Abstract][Full Text] [Related]
5. Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas.
Maitra A; Roberts H; Weinberg AG; Geradts J
Int J Cancer; 2001 Jan; 95(1):34-8. PubMed ID: 11241308
[TBL] [Abstract][Full Text] [Related]
6. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
Bachmann IM; Straume O; Akslen LA
Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.
Zacharek SJ; Xiong Y; Shumway SD
Cancer Res; 2005 Dec; 65(24):11354-60. PubMed ID: 16357142
[TBL] [Abstract][Full Text] [Related]
9. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H
Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
[TBL] [Abstract][Full Text] [Related]
10. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
11. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.
Craig C; Kim M; Ohri E; Wersto R; Katayose D; Li Z; Choi YH; Mudahar B; Srivastava S; Seth P; Cowan K
Oncogene; 1998 Jan; 16(2):265-72. PubMed ID: 9464545
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
Semczuk A; Miturski R; Skomra D; Jakowicki JA
Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
[TBL] [Abstract][Full Text] [Related]
13. Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats.
Fong LY; Nguyen VT; Farber JL; Huebner K; Magee PN
Cancer Res; 2000 Aug; 60(16):4589-95. PubMed ID: 10969811
[TBL] [Abstract][Full Text] [Related]
14. p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis.
Lukas J; Sørensen CS; Lukas C; Santoni-Rugiu E; Bartek J
Oncogene; 1999 Jul; 18(27):3930-5. PubMed ID: 10435615
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
[TBL] [Abstract][Full Text] [Related]
16. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
17. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27.
Zhang YW; Morita I; Ikeda M; Ma KW; Murota S
Oncogene; 2001 Jul; 20(31):4138-49. PubMed ID: 11464280
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma.
Asp J; Inerot S; Block JA; Lindahl A
J Orthop Res; 2001 Jan; 19(1):149-54. PubMed ID: 11332612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
